Day One Biopharmaceuticals (DAWN)
(Real Time Quote from BATS)
$12.97 USD
-0.09 (-0.69%)
Updated Jun 6, 2024 03:32 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -0.56 |
EPS Last Quarter | -0.72 |
Last EPS Surprise | -7.46% |
ABR | 1.60 |
Earnings ESP
|
14.35% |
---|---|
Current Year | -2.69 |
Next Year | -2.22 |
EPS (TTM) | -2.51 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.90M | 4.82M | 16.84M | 89.38M |
# of Estimates | 4 | 5 | 6 | 6 |
High Estimate | 1.30M | 6.00M | 21.30M | 135.23M |
Low Estimate | 0.56M | 2.38M | 5.78M | 25.67M |
Year ago Sales | 0.00M | 0.00M | NA | 16.84M |
Year over Year Growth Est. | NA | NA | NA | 430.79% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.56 | -0.71 | -2.69 | -2.22 |
# of Estimates | 6 | 5 | 8 | 8 |
Most Recent Consensus | 0.38 | -0.69 | -1.59 | -1.62 |
High Estimate | 0.38 | -0.65 | -1.59 | -1.62 |
Low Estimate | -0.78 | -0.78 | -3.08 | -3.00 |
Year ago EPS | -0.61 | -0.54 | -2.37 | -2.69 |
Year over Year Growth Est. | 8.20% | -31.48% | -13.50% | 17.29% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 0 | 1 | 1 |
Up Last 30 Days | 1 | 1 | 2 | 2 |
Up Last 60 Days | 2 | 2 | 2 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 3 | 5 | 5 |
Down Last 60 Days | 2 | 3 | 6 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.56 | -0.71 | -2.69 | -2.22 |
7 Days Ago | -0.75 | -0.71 | -2.83 | -2.23 |
30 Days Ago | -0.70 | -0.66 | -2.68 | -2.14 |
60 Days Ago | -0.71 | -0.67 | -2.66 | -2.12 |
90 Days Ago | -0.71 | -0.67 | -2.66 | -2.12 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.48 | -0.72 | -2.69 | -2.22 |
Zacks Consensus Estimate | -0.56 | -0.71 | -2.69 | -2.22 |
Earnings ESP | 14.35% | -2.05% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.72 | -0.64 | -0.54 | -0.61 | NA |
Estimate | -0.67 | -0.57 | -0.60 | -0.60 | NA |
Difference | -0.05 | -0.07 | 0.06 | -0.01 | -0.02 |
Surprise | -7.46% | -12.28% | 10.00% | -1.67% | -2.85% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more